Our in vivo data suggest that endothelial Rab7 elimination is more effective in reducing abnormal ZO-1 localization at BBB cell junctions after ischemic stroke compared to eGFP::Claudin-5 and VE-Cadherin proteins and preserving their total protein levels. This evidence concerns the gene CLDN5 and ischemic stroke.